Literature DB >> 19013769

Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.

Leah Kleinman1, Jeffrey Lieberman, Sanjay Dube, Richard Mohs, Yang Zhao, Bruce Kinon, William Carpenter, Philip D Harvey, Michael F Green, Richard S E Keefe, Lori Frank, Lee Bowman, Dennis A Revicki.   

Abstract

Existing measures for functional assessment do not adequately address the relationship between cognitive impairment and function. The Schizophrenia Outcomes Functioning Interview (SOFI) was developed to measure community functioning related to cognitive impairment and psychopathology. Following review of existing measures and discussion with experts, caregivers, and patients, content was generated for four domains: 1) living situation; 2) IADLs; 3) productive activities; and 4) social functioning. The final SOFI was constructed with items informing domain scores, and an interviewer-completed global rating for each domain. Psychometric characteristics of the SOFI were evaluated in a sample of 104 community residing patients with schizophrenia and their informants. Test-retest reliability was evaluated in a sub-sample of patient-informant dyads using ICC; all values were >0.70 for both patient-interviews (SOFI-P) and informant-interviews (SOFI-I). Inter-rater reliability ICCs ranged from 0.50 to 0.79 on a different sub-sample. The SOFI demonstrated adequate construct validity based on correlations with the PSP (range 0.58 to 0.76; p<0.0001) and the QLS (p<0.001). Some correlations between SOFI and PETiT scores were low to moderate (p<0.05). Discriminant validity was supported based on SOFI score comparisons for patient groups based on PANSS and BACS scores (p<0.05); SOFI scores differed between borderline and moderately ill patients as measured by the CGI-S (p<0.05). The SOFI expands on existing measures and more comprehensively captures functioning of patients in the real world than other performance-based (proxy) measures. The SOFI has good evidence supporting reliability and construct validity, and may be a useful measure of functional outcomes in schizophrenia.

Entities:  

Mesh:

Year:  2008        PMID: 19013769     DOI: 10.1016/j.schres.2008.10.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.

Authors:  M Riedel; I Spellmann; R Schennach-Wolff; M Obermeier; R Musil
Journal:  Qual Life Res       Date:  2010-10-05       Impact factor: 4.147

2.  Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning.

Authors:  Felicia Gould; Laura Stone McGuire; Dante Durand; Samir Sabbag; Carlos Larrauri; Thomas L Patterson; Elizabeth W Twamley; Philip D Harvey
Journal:  Neuropsychology       Date:  2015-02-02       Impact factor: 3.295

3.  Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.

Authors:  Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey
Journal:  Schizophr Res       Date:  2012-03-02       Impact factor: 4.939

4.  Validating the measurement of real-world functional outcomes: phase I results of the VALERO study.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

5.  Functional MRI examination of empathy for pain in people with schizophrenia reveals abnormal activation related to cognitive perspective-taking but typical activation linked to affective sharing.

Authors:  Damien Vistoli; Marie-Audrey Lavoie; Stephanie Sutliff; Philip L Jackson; Amélie M Achim
Journal:  J Psychiatry Neurosci       Date:  2017-06       Impact factor: 6.186

6.  Self-assessment of functional ability in schizophrenia: milestone achievement and its relationship to accuracy of self-evaluation.

Authors:  Felicia Gould; Samir Sabbag; Dante Durand; Thomas L Patterson; Philip D Harvey
Journal:  Psychiatry Res       Date:  2013-03-26       Impact factor: 3.222

7.  Functional Impairments and Theory of Mind Deficits in Schizophrenia: A Meta-analysis of the Associations.

Authors:  Élisabeth Thibaudeau; Caroline Cellard; Mélissa Turcotte; Amélie M Achim
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

8.  The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial.

Authors:  Lei Chen; Glenn Phillips; Joseph Johnston; Bruce J Kinon; Haya Ascher-Svanum; Sara Kollack-Walker; Paul Succop; Dieter Naber
Journal:  BMC Psychiatry       Date:  2011-12-28       Impact factor: 3.630

9.  The heterogeneity of antipsychotic response in the treatment of schizophrenia.

Authors:  M Case; V L Stauffer; H Ascher-Svanum; R Conley; S Kapur; J M Kane; S Kollack-Walker; J Jacob; B J Kinon
Journal:  Psychol Med       Date:  2010-10-07       Impact factor: 7.723

10.  The importance of measuring psychosocial functioning in schizophrenia.

Authors:  Sofia Brissos; Andrew Molodynski; Vasco Videira Dias; Maria Luísa Figueira
Journal:  Ann Gen Psychiatry       Date:  2011-06-24       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.